357 related articles for article (PubMed ID: 16952984)
21. Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
Zhang J; Merkle H; Hendrich K; Garwood M; From AH; Ugurbil K; Bache RJ
J Clin Invest; 1993 Aug; 92(2):993-1003. PubMed ID: 8349829
[TBL] [Abstract][Full Text] [Related]
22. Myocardial ATP hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophy.
Xiong Q; Zhang P; Guo J; Swingen C; Jang A; Zhang J
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H450-8. PubMed ID: 26024682
[TBL] [Abstract][Full Text] [Related]
23. Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis.
Vogt AM; Elsässer A; Pott-Beckert A; Ackermann C; Vetter SY; Yildiz M; Schoels W; Fell DA; Katus HA; Kübler W
Mol Cell Biochem; 2005 Oct; 278(1-2):223-32. PubMed ID: 16180108
[TBL] [Abstract][Full Text] [Related]
24. Energy metabolism in heart failure and remodelling.
Ingwall JS
Cardiovasc Res; 2009 Feb; 81(3):412-9. PubMed ID: 18987051
[TBL] [Abstract][Full Text] [Related]
25. Oxidative capacity in failing hearts.
Gong G; Liu J; Liang P; Guo T; Hu Q; Ochiai K; Hou M; Ye Y; Wu X; Mansoor A; From AH; Ugurbil K; Bache RJ; Zhang J
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H541-8. PubMed ID: 12714322
[TBL] [Abstract][Full Text] [Related]
26. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy.
Bache RJ; Zhang J; Murakami Y; Zhang Y; Cho YK; Merkle H; Gong G; From AH; Ugurbil K
Cardiovasc Res; 1999 Jun; 42(3):616-26. PubMed ID: 10533601
[TBL] [Abstract][Full Text] [Related]
27. Heart failure: is there an energy deficit contributing to contractile dysfunction?
Vogt AM; Kübler W
Basic Res Cardiol; 1998 Feb; 93(1):1-10. PubMed ID: 9538931
[TBL] [Abstract][Full Text] [Related]
28. Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction.
Peterzan MA; Clarke WT; Lygate CA; Lake HA; Lau JYC; Miller JJ; Johnson E; Rayner JJ; Hundertmark MJ; Sayeed R; Petrou M; Krasopoulos G; Srivastava V; Neubauer S; Rodgers CT; Rider OJ
Circulation; 2020 Jun; 141(24):1971-1985. PubMed ID: 32438845
[TBL] [Abstract][Full Text] [Related]
29. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance.
Liao R; Nascimben L; Friedrich J; Gwathmey JK; Ingwall JS
Circ Res; 1996 May; 78(5):893-902. PubMed ID: 8620610
[TBL] [Abstract][Full Text] [Related]
30. Cardiac performance and creatine kinase flux during inhibition of ATP synthesis in the perfused rat heart.
Mateo P; Stepanov V; Gillet B; Beloeil JC; Hoerter JA
Am J Physiol; 1999 Jul; 277(1):H308-17. PubMed ID: 10409210
[TBL] [Abstract][Full Text] [Related]
31. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system.
Shen W; Spindler M; Higgins MA; Jin N; Gill RM; Bloem LJ; Ryan TP; Ingwall JS
J Mol Cell Cardiol; 2005 Sep; 39(3):537-44. PubMed ID: 15978613
[TBL] [Abstract][Full Text] [Related]
32. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
Sanbe A; Tanonaka K; Niwano Y; Takeo S
J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851
[TBL] [Abstract][Full Text] [Related]
33. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts.
Tian R; Nascimben L; Ingwall JS; Lorell BH
Circulation; 1997 Aug; 96(4):1313-9. PubMed ID: 9286964
[TBL] [Abstract][Full Text] [Related]
34. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
35. Alterations in the myocardial creatine kinase system during chronic anaemic hypoxia.
Field ML; Clark JF; Henderson C; Seymour AM; Radda GK
Cardiovasc Res; 1994 Jan; 28(1):86-91. PubMed ID: 8111796
[TBL] [Abstract][Full Text] [Related]
36. Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.
Dzeja PP; Vitkevicius KT; Redfield MM; Burnett JC; Terzic A
Circ Res; 1999 May; 84(10):1137-43. PubMed ID: 10347088
[TBL] [Abstract][Full Text] [Related]
37. Decreased ATP production and myocardial contractile reserve in metabolic heart disease.
Luptak I; Sverdlov AL; Panagia M; Qin F; Pimentel DR; Croteau D; Siwik DA; Ingwall JS; Bachschmid MM; Balschi JA; Colucci WS
J Mol Cell Cardiol; 2018 Mar; 116():106-114. PubMed ID: 29409987
[TBL] [Abstract][Full Text] [Related]
38. Subcellular creatine kinase alterations. Implications in heart failure.
De Sousa E; Veksler V; Minajeva A; Kaasik A; Mateo P; Mayoux E; Hoerter J; Bigard X; Serrurier B; Ventura-Clapier R
Circ Res; 1999 Jul; 85(1):68-76. PubMed ID: 10400912
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of creatine kinase in an experimental model of low phosphocreatine and ATP in the normoxic heart.
Stepanov V; Mateo P; Gillet B; Beloeil JC; Lechene P; Hoerter JA
Am J Physiol; 1997 Oct; 273(4):C1397-408. PubMed ID: 9357786
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.
Bottomley PA; Weiss RG
Radiology; 2001 May; 219(2):411-8. PubMed ID: 11323465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
